Navigation Links
International scientists tackle obstacles to treating brain disorders
Date:12/20/2007

A research team led by scientists at the University of Minnesota Medical School and Oregon Health & Science University have outlined the challenges and made suggestions on how to advance research and improve treatments for brain disorders.

The review article is published in the January 2008 issue of the Lancet Neurology and will be available online on December 17.

Many neurological disorders are difficult to treat because of a natural barrier in the brain. The blood-brain barrier is a specialized system of cells that acts as a gatekeeper for the brain, blocking harmful substances from entering while allowing in necessary nutrients. The barrier is necessary to keep the brain and nervous system healthy. However, it also causes problems in medication delivery because it treats medications as the enemy, preventing the therapeutic agents from doing their job.

In order to develop new and innovative treatments for diseases such as stroke, Alzheimers disease, and multiple sclerosis, researchers have to find ways to overcome the blood-brain barrier, said Lester Drewes, Ph.D., professor of biochemistry and molecular biology at the University of Minnesota Medical School, Duluth campus. The review has resulted in a number of recommendations to establish and fund research centers that will focus on overcoming these barriers. Drewes is the founding president of the International Brain Barriers Society, a forum for scientists to share their research and fast track discoveries related to the blood-brain barrier. He and 14 other scientists wrote the review.

Edward Neuwelt, M.D., a professor of neurology and neurological surgery in the OHSU School of Medicine and a physician at the Portland Veterans Affairs Medical Center, is among the most active scientists in the international community studying the blood-brain barrier. Neuwelt also was a major participant in the review.

The blood-brain barrier is the Achilles heel for treating virtually all neurological disorders, said Neuwelt, director of OHSUs Blood-Brain Barrier Program. However, like the Great Wall of China, there are portals in the barrier that, with proper research, offer a way through. Neuwelt studies ways to open the blood-brain barrier. Other investigators are studying a Trojan horse approach in which therapeutic agents are attached to parts of proteins, such as insulin, that normally cross the barrier.

The researchers examined six topic areas surrounding brain barriers that need to be addressed in order to advance scientific understanding and ultimately improve patient care: Inflammation, injury, tumors, neurodegeneration, specialized barriers, and delivery.

When the brain is injured, as in the case of a stroke, the blood-brain barrier is altered near the site of injury. Changes in the barrier have an effect on how the injury progresses and how much neural tissue is damaged. The researchers suggest that better imaging techniques must be developed to better view the barrier near the injury site.

Improved imaging will also help in furthering research into the effect of brain barriers on tumors. Current imaging techniques do not accurately show the tumors size, location, type, and response to therapy.

In the study of neurodegenerative diseases, such as Parkinsons, the researchers said often brain barrier is overlooked or only viewed as a barrier to drug delivery. The article suggests that brain barriers play a larger role in the progression of degenerative disease, and that researchers should focus on how the changes in the barriers relate to brain degeneration during the aging process.

In addition to the blood-brain barrier, there are other more specialized barriers in the brain that function in different ways. The scientists suggest that more research needs to be done on how these barriers act alone and in concert with other barriers. Currently there are only limited experimental models of these specialized barriers, and thus little is understood about how they function.

Drug delivery to the brain is extremely complicated. Researchers estimate that very little of therapeutic drugs make it beyond the blood-brain barrier and because of this, progress developing therapies for brain disease is very slow.

The researchers suggest more interdisciplinary research into drug delivery options that would bring together biologists, pharmaceutical scientists, and bioengineers.


'/>"/>

Contact: Sara Buss
buss@umn.edu
612-626-7037
University of Minnesota
Source:Eurekalert

Related biology news :

1. BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo
2. ESMO International Symposium on Immunology
3. Conservation International and Toyota partner to protect Philippines rain forests
4. International team shows mercury concentrations in fish respond quickly to increased deposition
5. International team shows mercury concentrations in fish respond quickly to increased deposition
6. BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo
7. Youngstown, Ohio Police Award Mobile Data Contract to BIO-key(R) International
8. Clemson physicist addresses international forum on thermoelectric energy
9. US launch of international consultation for new responsible nanocode
10. International team of scientists warns of climate changes impact on global river flow
11. BIO-key International Showcasing Innovative Public Safety Solutions at 2007 IACP Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... -- The American College of Medical Genetics and Genomics was once ... one of the fastest-growing trade shows during the Fastest 50 ... Las Vegas . Winners ... each of the following categories: net square feet of paid ... The 2015 ACMG Annual Meeting was ranked 23 out of ...
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... 2016 Part of 5m$ Investment in ... ... Aptuit, LLC today announced that it had successfully completed the ... compounds have increased the Screening Collection to over 400,000. The ... capabilities of the company. This expansion, complemented by new robotics ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... advanced technology applications, introduces the 5th generation, ultra-bright, Laser-Driven Light Source, the EQ-77, ... Light Source (LDLS™) technology, the EQ-77 offers higher radiance and irradiance from a ...
(Date:11/30/2016)... ... November 30, 2016 , ... With growth rates averaging more than 30% ... and look forward to continuing their expansion in their new office space. The new ... been traditionally favoured by the creative industries, so Random42 Scientific Communication will fit right ...
(Date:11/30/2016)... GREENWICH, Connecticut , November 30, 2016 ... für die integrierte Medikamententdeckung    ... , , ... führende Prüfbibliothek erfolgreich erweitert zu haben. Zusätzliche 150.000 neuartige ... neuen Substanzen wurden sorgfältig ausgewählt, um die starken Entdeckungsfähigkeiten ...
Breaking Biology Technology: